Literature DB >> 3511095

Control of heme metabolism with synthetic metalloporphyrins.

A Kappas, G S Drummond.   

Abstract

Studies with synthetic metal-porphyrin complexes in which the central iron atom of heme is replaced by other elements indicate that those heme analogues that cannot be enzymatically degraded to bile pigments possess novel biological properties that may have considerable clinical as well as experimental value. Such studies have revealed the important role that the central metal atom plays in determining the physiological and pharmacological properties of metal-porphyrin complexes; and they have demonstrated that the form in which animals and humans are exposed to trace metals, i.e., inorganic, organified, porphyrin-chelated, etc., can be of great importance in determining the biological responses that such elements elicit, especially with respect to actions on heme synthesis and degradation and cytochrome P-450 formation and function. Study of the biological properties of synthetic metalloporphyrins represents a potentially fruitful area of research and the results may have significant value for basic as well as clinical disciplines.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3511095      PMCID: PMC423351          DOI: 10.1172/JCI112309

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Cyanide intoxication: protection with cobaltous chloride.

Authors:  G Isom; J L Way
Journal:  Toxicol Appl Pharmacol       Date:  1973-03       Impact factor: 4.219

2.  The influence of organometals on heme metabolism. In vivo and in vitro studies with organotins.

Authors:  D W Rosenberg; G S Drummond; A Kappas
Journal:  Mol Pharmacol       Date:  1982-01       Impact factor: 4.436

3.  Prolonged induction of hepatic haem oxygenase and decreases in cytochrome P-450 content by organotin compounds.

Authors:  D W Rosenberg; G S Drummond; H C Cornish; A Kappas
Journal:  Biochem J       Date:  1980-08-15       Impact factor: 3.857

4.  Steroid induction of porphyrin synthesis in liver cell culture. I. Structural basis and possible physiological role in the control of heme formation.

Authors:  S Granick; A Kappas
Journal:  J Biol Chem       Date:  1967-10-25       Impact factor: 5.157

5.  The cytochrome P-450-depleted animal: an experimental model for in vivo studies in chemical biology.

Authors:  G S Drummond; A Kappas
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

6.  Studies on the mechanism of Sn-protoporphyrin suppression of hyperbilirubinemia. Inhibition of heme oxidation and bilirubin production.

Authors:  C S Simionatto; K E Anderson; G S Drummond; A Kappas
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

7.  Tin protoporphyrin inhibits carbon monoxide production in adult mice.

Authors:  G S Milleville; M D Levitt; R R Engel
Journal:  Pediatr Res       Date:  1985-01       Impact factor: 3.756

8.  Control of heme oxygenase and plasma levels of bilirubin by a synthetic heme analogue, tin-protoporphyrin.

Authors:  A Kappas; G S Drummond; C S Simionatto; K E Anderson
Journal:  Hepatology       Date:  1984 Mar-Apr       Impact factor: 17.425

9.  Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation.

Authors:  G S Drummond; A Kappas
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

10.  Long-term administration of massive doses of Sn-protoporphyrin in anemic mutant mice (sphha/sphha).

Authors:  S Sassa; G S Drummond; S E Bernstein; A Kappas
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

View more
  33 in total

1.  Heme oxygenase-1 induction enhances cell survival and restores contractility to unvascularized three-dimensional adult cardiomyocyte grafts implanted in vivo.

Authors:  Shunsuke Kawamoto; Jerald P Flynn; Qun Shi; Sana W Sakr; Jun Luo; Margaret D Allen
Journal:  Tissue Eng Part A       Date:  2011-03-23       Impact factor: 3.845

Review 2.  HO-1 overexpression and underexpression: Clinical implications.

Authors:  George S Drummond; Jeffrey Baum; Menachem Greenberg; David Lewis; Nader G Abraham
Journal:  Arch Biochem Biophys       Date:  2019-08-16       Impact factor: 4.013

3.  Zinc porphyrins: potent inhibitors of hematopoieses in animal and human bone marrow.

Authors:  J D Lutton; N G Abraham; G S Drummond; R D Levere; A Kappas
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

Review 4.  Translational Significance of Heme Oxygenase in Obesity and Metabolic Syndrome.

Authors:  Nader G Abraham; Joshua M Junge; George S Drummond
Journal:  Trends Pharmacol Sci       Date:  2015-10-26       Impact factor: 14.819

5.  Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats.

Authors:  R D Levere; P Martasek; B Escalante; M L Schwartzman; N G Abraham
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

6.  Targeted delivery of a heme oxygenase inhibitor with a lyophilized liposomal tin mesoporphyrin formulation.

Authors:  J B Cannon; C Martin; G S Drummond; A Kappas
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

7.  Inhibition of plasminogen activator inhibitor-1 expression in vascular smooth muscle cells by protoporphyrins through a heme oxygenase-independent mechanism.

Authors:  Xilin Long; Andrew I Schafer
Journal:  Mol Cell Biochem       Date:  2008-03-16       Impact factor: 3.396

8.  Effects of age, phenobarbital, beta-naphthoflavone and dexamethasone on rat hepatic heme oxygenase.

Authors:  A Plewka; M Bienioszek
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

9.  Dual control mechanism for heme oxygenase: tin(IV)-protoporphyrin potently inhibits enzyme activity while markedly increasing content of enzyme protein in liver.

Authors:  M K Sardana; A Kappas
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

10.  Topical hypochlorite ameliorates NF-κB-mediated skin diseases in mice.

Authors:  Thomas H Leung; Lillian F Zhang; Jing Wang; Shoucheng Ning; Susan J Knox; Seung K Kim
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.